I want to thank you, the viewer, for... Posted by Meteorologist Ben Pine on Monday, March 17, 2025 Taking his place as chief meteorologist is Mallory Schnell; she joined the team and returned ...

Around this time last year, Akero was riding high on positive phase 2b data for its candidate non-alcoholic steatohepatitis (NASH) therapy, but new data has dented optimism about the project.

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...